A study of the Galleri multicancer early detection test did not meet its primary endpoint of reducing the detection of ...

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

Imagine detecting cancer before it causes pain, weight loss, or any noticeable symptoms. That possibility is driving growing interest in multi-cancer blood tests, with the Galleri test emerging as one ...

TORONTO, Nov. 3, 2025 /CNW/ - Manulife Canada today announced it is the first insurance company in Canada to offer access to GRAIL's Galleri ® multi-cancer early detection test, to eligible life ...

Multicancer blood tests have for years been hyped as a potential breakthrough in early cancer detection. But with news that one of the big names in the field, the Galleri test, failed to meet its ...

MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, LLC, a healthcare company whose mission is to detect cancer early, today announced a collaboration with the Knight Cancer Institute at Oregon Health & ...

"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...

BOSTON, Feb. 23, 2023 /PRNewswire/ -- Today, John Hancock, a unit of Manulife (NYSE: MFC), announced it will expand access to GRAIL's Galleri ® multi-cancer early detection test to eligible life ...

Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. It should be noted that the Galleri test not currently ...